A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.
A patient featured in recent Derm IQ is back after having her baby. As a refresher, she is 27-years old with a long-standing history of atopic dermatitis (AD), which has been severe since childhood and often worsens during winter, occasionally requiring hospitalization. She was seeking advice to not pass her severe AD to her unborn child.
Today, returns to your clinic post-pregnancy and breastfeeding, seeking systemic therapy for her poorly controlled AD. Considering her various health concerns, she prefers a medication that could simultaneously manage her other conditions. After discussing several options, you decide to start her on an injectable medication for AD. Which of the following conditions is not typically comanaged with current injectable medications for AD?